Successful protocol of anaesthesia for measuring transepithelial nasal potential difference in spontaneously breathing mice

Laboratory Animals

Volumn 40, Issue 1, 2006, Pages 43-52

  Leal, T ^a,b   Lebacq, J ^a   Vanbinst, R ^a   Lederman, Ch ^a   De Kock, M ^a   Wallemacq, P ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Anaesthetics, combined; Cystic fibrosis; Mass spectrometry; Mice; Nasal potential difference

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMILORIDE; ATIPAMEZOLE; CHLORIDE ION; CLONIDINE; DROPERIDOL; FENTANYL; FENTANYL JANSSEN; MEDETOMIDINE; NALOXONE; OPIATE ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; BREATHING RATE; CELL MEMBRANE POTENTIAL; CELL MEMBRANE TRANSPORT; CHLORIDE TRANSPORT; CONTROLLED STUDY; CYSTIC FIBROSIS; DEPOLARIZATION; DOSE RESPONSE; DRUG BLOOD LEVEL; ELECTRIC POTENTIAL; EYELID REFLEX; ION TRANSPORT; MASS SPECTROMETRY; MOUSE; NASAL POTENTIAL DIFFERENCE; NONHUMAN; NOSE MUCOSA; PUPIL REFLEX; REPOLARIZATION; WITHDRAWAL REFLEX;

ANESTHESIA; ANESTHETICS, COMBINED; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; DROPERIDOL; ELECTRIC CONDUCTIVITY; EPITHELIAL CELLS; FEMALE; FENTANYL; HEART RATE; MALE; MEDETOMIDINE; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; NASAL MUCOSA; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

ANIMALIA;

EID: 33644787306     PISSN: 00236772     EISSN: None     Source Type: Journal    
DOI: 10.1258/002367706775404480     Document Type: Article

References (25)

1. Chaturvedi AK, Rao NG, Baird JR (1990) A death due to self-administered fentanyl. Journal of Analytical Toxicology 14, 385-7
2. Egan ME, Pearson M, Weiner SA, et al. (2004) Curcumin, a major constituent of tumeric, corrects cystic fibrosis defects. Science 304, 600-2
3. Flanagan RJ (1998) Guidelines for the interpretation of analytical toxicology results and unit of measurement conversion factors. Annals of Clinical Biochemistry 35, 261-7
4. Freye E, Kuschinsky K (1976) Effects of fentanyl and droperidol on the dopamirie metabolism of the rat. Pharmacology 14, 1-7
5. Ghosal S, Taylor CJ, Colledge WH, Ratcliff R, Evans MJ (2000) Sodium channel blockers and uridine triphosphate: effects on nasal potential difference in cystic fibrosis mice. European Respiratory Journal 15, 146-50
6. Ghosal S, Taylor CJ, McGray J (1996) Modification of the nasal membrane potential difference with inhaled amiloride and loperamide in the cystic fibrosis (CF) mouse. Thorax 51, 1229-32
7. - secretion in nasal epithelia of CF mice. American Journal of Physiology 266, C1478-83
8. Hardiman KM, Lindsey JR, Matalon S (2001) Lack of amiloride-sensitive transport across alveolar and respiratory epithelium of iNOS (-/-) mice in vivo. American Journal of Physiology 281, L722-31
9. Hellebrekers LJ, de Boer EJ, van Zuylen MA, Vosmeer H (1997) A comparison between medetomidineketamine and medetomidine-propofol anaesthesia in rabbits. Laboratory Animals 31, 58-69
10. Hem A, Smith AJ, Solberg P (1998) Saphenous vein puncture for blood sampling of the mouse, rat, hamster, gerbil, guineapig, ferret and mink. Laboratory Animals 32, 364-8
11. Hill GE, Anderson JL, Whitten CW (1999) Ketamine inhibits agonist-induced cAMP accumulation increase in human airway smooth muscle cells. Canadian Journal of Anaesthesia 46, 1172-7
12. Knowles MR, Gatzy GT, Boucher R (1981) Increased bioelectrical potential difference across respiratory epithelia in cystic fibrosis. New England Journal of Medicine 305, 1489-95
13. Knowles MR, Paradiso AM, Boucher RC (1995) In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Human Gene Therapy 6, 445-55
14. Leal T, Lebacq J, Lebecque P, Cumps J, Wallemacq P (2003a) Modified method to measure nasal potential difference. Clinical Chemistry and Laboratory Medicine 4, 64-7
15. Leal T, Lebacq J, Wallemacq P, et al. (2003b) Decreased chloride secretion by nasal epithelium of P2Y4-null mice. Journal of Cystic Fibrosis 2, S14
16. Middleton PG, Geddes DM, Alton EWFW (1994) Protocols for in vivo measurements of the ion transport defects in cystic fibrosis nasal epithelium. European Respiratory Journal 7, 2050-6
17. Meert TF, De Kock M (1994) Potentiation of the analgesic properties of fentanyl-like opioids with alpha-2 adrenoceptor agonists in rats. Anesthesiology 81, 678-88
18. Mery S, Gross EA, Joyner DR, Godo M, Morgan KT (1994) Nasal diagrams: a tool for recording the distribution of nasal lesions in rats and mice. Toxicologic Pathology 22, 353-72
19. Sato T, Hirota K, Matsuki A, Zsigmond EK, Rabito SF (1996) Droperidol inhibits tracheal contraction induced by serotonin, histamine or carbachol in guinea pigs. Canadian Journal of Anaesthesia 43, 172-8
20. Shibata O, Saito M, Makita T, Morooka H, Sumikawa K (2003) Droperidol attenuates contractile and phosphatidylinositol responses of rat trachea. Pharmacology 68, 24-8
21. Smith SN, Middleton PG, Chadwick S, et al. (1999) The in vivo effects of milrinone on the airways of cystic fibrosis mice and human subjects. American Journal of Respiratory Cell and Molecular Biology 20, 129-34
22. Van Doorninck JH, French PJ, Verbeek E, et al. (1995) A mouse model for the cystic fibrosis DF508 mutation. EMBO Journal 14, 4403-11
23. Virtanen R (1989) Pharmacological profiles of medetomidine and its antagonist, atipamezole. Acta Veterinaria Scandinavica Supplement 85, 29-37
24. Vuckovic S, Ivanovic M, Prostran M, et al. (1998) Higher environmental temperature potentiates cataleptic effect of fentanyl in rats. Japanese Journal of Pharmacology 78, 523-7
25. Wallemacq PE, Vanbinst R, Asta S, Cooper D (2003) High-throughput liquid chromatography-tandem mass spectrometric analysis of sirolimus in whole blood. Clinical Chemistry and Laboratory Medicine 41, 921-5